Menu
A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: The 2020 edition of the MauiDerm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically relevant material was also presented in poster format. For those of
Vol. 13, No. 5 • May 2020 Dear Colleagues: Welcome to the May 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with a retrospective analysis from Patel et al, in which the authors investigated the efficacy of fixed-combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) foam for the treatment
J Clin Aesthet Dermatol. 2020;13(5):12–18 by Dharm S. Patel, PhD; Karen A. Veverka, PhD; Jes B. Hansen, PhD; Paul S. Yamauchi, MD; Javier Alonso-Llamazares, MD; and Mark Lebwohl, MD Drs. Patel and Veverka are with LEO Pharma in Madison, New Jersey. Dr. Hansen is with LEO Pharma in Ballerup, Denmark. Dr. Yamauchi is with the
J Clin Aesthet Dermatol. 2020;13(5):19–23 by Peter P. Rullan, MD; Rachel Olson, BS; and Kachiu C. Lee, MD, MPH Dr. Rullan is with the Department of Dermatology, University of California San Diego in La Jolla, California and the Dermatology Institute in Chula Vista, California. Ms. Olson is with the Dermatology Institute in Chula Vista, California.
J Clin Aesthet Dermatol. 2020;13(5):24–27 by Anny Xiao, DO; Renee Lucero, DO; and William T. Kirby, DO, FAOCD Drs. Xiao, Lucero, and Kirby are with the Western University of Health Sciences in Pomona, California. Dr. Kirby is also with LaserAway in Hermosa Beach, California. FUNDING: No funding was provided for this study. DISCLOSURES: The authors
